CD8A and graft versus host disease: Thus, CD8+ Tregs will be advantageous, particularly in organ transplantation or graft versus host disease (GVHD) since suppression will additionally occur in all allogeneic cells, including ECs of vascularized grafts or host organs in GVHD.